Track Forward Pharma A/S's net income ($0) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2021
Trailing 12 months ending Dec 2021
Loading...
Loading...
As of the most recent data (December 2021), FWP shows a net income of $0. That compares with $910M in the prior-year period — down 100.0% year over year. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, FWP's net income is now $0 (was $910M) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Forward Pharma A/S is outperforming or lagging.
The Healthcare sector average net income is about $16B. Forward Pharma A/S is at $0, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how FWP stacks up against individual peers as well.
Tracking FWP's net income over time shows whether Forward Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $910M in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net income page, Stockcircle has Forward Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $0) with ownership activity and broader fundamentals.